36 /100
MEDIUM RISK
Score updated May 28, 2026

SYRE — Spyre Therapeutics, Inc. Dilution Risk Tracker

Track SYRE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track SYRE — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
60
💰 Cash Runway
0
📊 Float Risk
10
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

Watch
Minor dilution signals detected
19%
💰 Capital Raise 38%
• Active shelf registration ($500M, 8% of market cap)
• Active ATM program with $403M remaining capacity
🔔 Track SYRE — Get forecast alerts →

💹 Market Data

Market Cap$6.30B
Shares Outstanding86.84M
Float80.93M
Cash$741.47M
DebtN/A
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 25.8% shares (2025Q4 vs prior)
155 institutional holders · 82.02M shares
#1 FMR LLC 11.64M shares
#2 BlackRock, Inc. 5.52M shares
#3 RTW INVESTMENTS, LP 4.17M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest12.22M
Days to Cover10.0
% of Float15.1%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2024
xbrl XBRL WARRANT Dec 31, 2022
8-K 8K EVENT Apr 16, 2026
424B5 ATM Apr 16, 2026
424B5 ATM Apr 13, 2026
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track SYRE Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking SYRE — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for SYRE
📊 SYRE FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 SYRE Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.